Paul Fonteyne
DirectoratAmylyx Pharmaceuticals· In proxies 2023–2025
Paul Fonteyne sits on 11 public boards.
Boards1
- Amylyx PharmaceuticalsDirector · 3 yr on the boardIndependentCompensation (Chair), Science and Technology—Paid as an executive
Board seats come from each company's latest proxy statement.
Experience
- Amylyx PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrStock in role -19%
- Corium, LLCPublic company · 2 yr
- Director2024 – Present · 2 yrNo stock prices for these years
- Apnimed PharmaceuticalsPublic company · 3 yr
- Director2023 – Present · 3 yrNo stock prices for these years
- Apellis PharmaceuticalsPublic company · 6 yr
- Director2020 – Present · 6 yrNo stock prices for these years
- DalCor, Inc.Public company · 7 yr
- Director2019 – Present · 7 yrNo stock prices for these years
- Ypsomed AGPublic company · 8 yr
- Director2018 – Present · 8 yrNo stock prices for these years
- Covetrus Inc.Public company · 5 yr
- Director2021 – Present · 5 yrNo stock prices for these years
- AMAG Pharmaceuticals, Inc.Public company · 7 yr
- Director2019 – Present · 7 yrNo stock prices for these years
- Gelesis Holdings, Inc.Public company · 8 yr
- Director2018 – Present · 8 yrNo stock prices for these years
- ResTORbio Inc.Public company · 9 yr
- Director2017 – Present · 9 yrNo stock prices for these years
- Adicet Bio, Inc.Public company
- Director? – PresentNo stock prices for these years
Roles come from the proxy statements of each company.
Activity
No new filings about this person in the feed.
Two people shown as one, or a wrong number?